AstraZeneca
The Senior Director, US Evidence – Respiratory & Immunology (Real-World Evidence) is a strategic leadership role within US Medical, responsible for shaping and delivering the Real-World Evidence (RWE) strategy for the R&I portfolio. This leader directs a team of RWE Directors, designing and executing research studies that demonstrate product value, inform medical strategy, and address critical evidence gaps. The role partners with cross-functional teams to ensure RWE outputs translate into practice-changing interventions and champions the responsible adoption of AI-enabled technologies to accelerate RWE workflows.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Real World Evidence (RWE) Expert Solutions (UK)
City of Pierre, South Dakota
Real World Evidence (RWE) Expert Solutions (BE)
City of Pierre, South Dakota
Director, RWE, CMH
Eli Lilly and Company
RWE Strategy Lead Developed Brands, Immunology
UCB
Real World Evidence (RWE) Expert Solutions (BE)
City of Winnipeg
RWE Strategy Lead Developed Brands, Immunology
UCB